Vitiligo immunopathogenesis: Insight of immune components and prospects of emerging immunotherapies.

Vitiligo is an acquired depigmenting disease characterized by the loss of pigmentation from the skin due to selective killing of pigment forming cells (melanocytes) by cytotoxic T cells (CD8+ T cells). The pathogenesis of vitiligo has broad spectrum…

Preview only. Read the full abstract at the source